Adolor Entereg NDA For Postoperative Ileus Slated For First Half 2004
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Adolor plans to submit an NDA for its postoperative ileus agent Entereg (alvimopan) in the first half of 2004.